Search Results - "Radiopharmaceutical"

Validation of a size exclusion method for concomitant purification and formulation of peptide radiopharmaceuticals by Sebastian Martin, Lennard Wendlinger, Alexandra Litvinenko, Radmila Faizova, Margret Schottelius

Connect to this object online.

Special Issue "Targets, Tracers and Translation Novel Radiopharmaceuticals Boost Nuclear Medicine" by Gerald Reischl

Connect to this object online.

Prospects for Radiopharmaceuticals as Effective and Safe Therapeutics in Oncology and Challenges of Tumor Resistance to Radiotherapy by Ekaterina Nikolova, Dimitar Tonev, Nikolai Zhelev, Vladimir Neychev

Connect to this object online.

Influence of radiation on endotoxin test using the PTS TM for 18-FDG radiopharmaceutical by Ralph Santos-Oliveira

Connect to this object online.

Radiolabeled tirofiban – a potential radiopharmaceutical for detection of deep venous thrombosis by Darkovska-Serafimovska M, Janevik-Ivanovska E, Djorgoski I, Arsova-Sarafinovska Z, Zdravkovska M, Balkanov T, Ugresic N

Connect to this object online.

Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals by Xiaona Sun, Yuxuan Wu, Xingkai Wang, Xin Gao, Siqi Zhang, Zhicheng Sun, Ruping Liu, Kuan Hu

Connect to this object online.

Safe use of radiopharmaceuticals in patients with chronic kidney disease: a systematic review by Nanno Schreuder, Iris de Romijn, Pieter L. Jager, Jos G. W. Kosterink, Eugène P. van Puijenbroek

Connect to this object online.

Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives by Eline L. Hooijman, Valery Radchenko, Sui Wai Ling, Mark Konijnenberg, Tessa Brabander, Stijn L. W. Koolen, Erik de Blois

Connect to this object online.

Natural product-based radiopharmaceuticals: Focus on curcumin and its analogs, flavonoids, and marine peptides by Hendris Wongso

Connect to this object online.

Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals by Aruna Korde, Renata Mikolajczak, Petra Kolenc, Penelope Bouziotis, Hadis Westin, Mette Lauritzen, Michel Koole, Matthias Manfred Herth, Manuel Bardiès, Andre F. Martins, Antonio Paulo, Serge K. Lyashchenko, Sergio Todde, Sangram Nag, Efthimis Lamprou, Antero Abrunhosa, Francesco Giammarile, Clemens Decristoforo

Connect to this object online.

Intra-Arterial Delivery of Radiopharmaceuticals in Oncology: Current Trends and the Future of Alpha-Particle Therapeutics by Nathan Kauffman, James Morrison, Kevin O'Brien, Jinda Fan, Kurt R. Zinn

Connect to this object online.

A Multi-Criteria Decision Aid Tool for Radiopharmaceutical Selection in Tau PET Imaging by Ilker Ozsahin, Efe Precious Onakpojeruo, Berna Uzun, Dilber Uzun Ozsahin, Tracy A. Butler

Connect to this object online.

Synthesis and biological evaluation of 125I-erythropoietin as a potential radiopharmaceutical agent for tumours by Gonçalo dos Santos Clemente, Vera Lúcia Serra Duarte

Connect to this object online.

Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets by Alexandra I. Fonseca, Vítor H. Alves, Sérgio J. C. do Carmo, Magda Silva, Ivanna Hrynchak, Francisco Alves, Amílcar Falcão, Antero J. Abrunhosa

Connect to this object online.

Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals by Nic Gillings, Olaug Hjelstuen, Jim Ballinger, Martin Behe, Clemens Decristoforo, Philip Elsinga, Valentina Ferrari, Petra Kolenc Peitl, Jacek Koziorowski, Peter Laverman, Thomas L. Mindt, Oliver Neels, Meltem Ocak, Marianne Patt, Sergio Todde

Connect to this object online.

A suitable time point for quantifying the radiochemical purity of 225Ac-labeled radiopharmaceuticals by James M. Kelly, Alejandro Amor-Coarasa, Elizabeth Sweeney, Justin J. Wilson, Patrick W. Causey, John W. Babich

Connect to this object online.

Pharmacological activities and potential use of bovine colostrum for peptide-based radiopharmaceuticals: A review by Crhisterra Ellen Kusumaningrum, Eva Maria Widyasari, Maula Eka Sriyani, Hendris Wongso

Connect to this object online.

Lutathera^®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy by Ute Hennrich, Klaus Kopka

Connect to this object online.

Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework by Aruna Korde, Marianne Patt, Svetlana V. Selivanova, Andrew M. Scott, Rolf Hesselmann, Oliver Kiss, Natesan Ramamoorthy, Sergio Todde, Sietske M. Rubow, Luther Gwaza, Serge Lyashchenko, Jan Andersson, Brian Hockley, Ravindra Kaslival, Clemens Decristoforo

Connect to this object online.

A Fast and Simple Method for the Determination of TBA in ¹⁸F-Labeled Radiopharmaceuticals by Nils Erik Halvorsen, Ole Heine Kvernenes

Connect to this object online.